Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
By Frank I. Marcus, W. McKenna, D. Sherrill, C. Basso, B. Bauce, David A. Bluemke, H. Calkins, D. Corrado, M. Cox, James P. Daubert and 15 more. European Heart Journal, 2010
3,072 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Rheumatology
View Paper: https://www.semanticscholar.org/paper/6517a1ada2d21b4c0f1179eaedd79b43a77223fa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. (2019, methodology): “500 in 24 hours) and/ or VT of LBBB morphology in the absence of other heart disease.(10,19,39,40) In patients with suspected ACM who do not meet the diagnostic criteria for ARVC, the evaluation should be systematic to establish the diagnosis of other genetic and nongenetic forms of ACM, with repeat”
- Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated Desmosomal Mutation Carriers (2013, methodology): “The diagnosis of ARVD/C was based on the presence of major and minor diagnostic criteria according to the TFC (24).”
- HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). (2011, background): “Clinical diagnosis is based on demonstration of characteristic ECG, arrhythmic, structural, and/or histological abnormalities.(182,184) A confirmed family history and/or the presence of a definite or probable disease-causing mutation also contributes to diagnosis.”